Lee Youri, Kim Yu-Jin, Jung Yu-Jin, Kim Ki-Hye, Kwon Young-Man, Kim Seung Il, Kang Sang-Moo
Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303 USA.
Division of Life Science, Korea Basic Science Institute, Daejeon, 305-333 South Korea.
J Anal Sci Technol. 2015;6(1):3. doi: 10.1186/s40543-015-0047-4. Epub 2015 Feb 5.
Natural infection and then recovery are considered to be the most effective means for hosts to build protective immunity. Thus, mimicking natural infection of pathogens, many live attenuated vaccines such as influenza virus, and yellow fever vaccine 17D were developed and have been successfully used to induce protective immunity. However, humans fail to generate long-term protective immunity to some pathogens after natural infection such as influenza virus, respiratory syncytial virus (RSV), and human immunodeficiency virus (HIV) even if they survive initial infections. Many vaccines are suboptimal since much mortality is still occurring, which is exampled by influenza and tuberculosis. It is critically important to increase our understanding on protein components of pathogens and vaccines as well as cellular and host responses to infections and vaccinations. Here, we highlight recent advances in gene transcripts and protein analysis results in the systems biology to enhance our understanding of viral pathogens, vaccines, and host cell responses.
自然感染并随后康复被认为是宿主建立保护性免疫的最有效手段。因此,模仿病原体的自然感染,开发了许多减毒活疫苗,如流感病毒疫苗和黄热病17D疫苗,并已成功用于诱导保护性免疫。然而,人类在自然感染某些病原体(如流感病毒、呼吸道合胞病毒(RSV)和人类免疫缺陷病毒(HIV))后,即使在初次感染中存活下来,也无法产生长期保护性免疫。许多疫苗效果欠佳,因为仍有大量死亡发生,流感和结核病就是例证。加深我们对病原体和疫苗的蛋白质成分以及细胞和宿主对感染及疫苗接种反应的理解至关重要。在此,我们重点介绍系统生物学中基因转录物和蛋白质分析结果的最新进展,以增进我们对病毒病原体、疫苗和宿主细胞反应的理解。